Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 Aug;78(4):504–507. doi: 10.1038/bjc.1998.522

What is the role of radiation-chemotherapy in the radical non-surgical management of carcinoma of the oesophagus? Upper GI Cancer Working Party of the UK Medical Research Council.

P Price 1, P J Hoskin 1, T Hutchinson 1, S Stenning 1
PMCID: PMC2063077  PMID: 9716034

Abstract

The optimal radical non-surgical management of carcinoma of the oesophagus has yet to be determined. The combination of high-dose radiotherapy with chemotherapy is being explored, particularly in North America. The MRC Upper GI Working Party has debated the areas where there is scientific uncertainty and which clinical trials may be appropriate to undertake in the UK.

Full text

PDF
504

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Araújo C. M., Souhami L., Gil R. A., Carvalho R., Garcia J. A., Froimtchuk M. J., Pinto L. H., Canary P. C. A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer. 1991 May 1;67(9):2258–2261. doi: 10.1002/1097-0142(19910501)67:9<2258::aid-cncr2820670908>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  2. Bhansali M. S., Vaidya J. S., Bhatt R. G., Patil P. K., Badwe R. A., Desai P. B. Chemotherapy for carcinoma of the esophagus: a comparison of evidence from meta-analyses of randomized trials and of historical control studies. Ann Oncol. 1996 Apr;7(4):355–359. doi: 10.1093/oxfordjournals.annonc.a010601. [DOI] [PubMed] [Google Scholar]
  3. Denham J. W., Burmeister B. H., Lamb D. S., Spry N. A., Joseph D. J., Hamilton C. S., Yeoh E., O'Brien P., Walker Q. J. Factors influencing outcome following radio-chemotherapy for oesophageal cancer. The Trans Tasman Radiation Oncology Group (TROG) Radiother Oncol. 1996 Jul;40(1):31–43. doi: 10.1016/0167-8140(96)01762-8. [DOI] [PubMed] [Google Scholar]
  4. Flam M., John M., Pajak T. F., Petrelli N., Myerson R., Doggett S., Quivey J., Rotman M., Kerman H., Coia L. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996 Sep;14(9):2527–2539. doi: 10.1200/JCO.1996.14.9.2527. [DOI] [PubMed] [Google Scholar]
  5. Herskovic A., Martz K., al-Sarraf M., Leichman L., Brindle J., Vaitkevicius V., Cooper J., Byhardt R., Davis L., Emami B. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992 Jun 11;326(24):1593–1598. doi: 10.1056/NEJM199206113262403. [DOI] [PubMed] [Google Scholar]
  6. Keane T. J., Harwood A. R., Elhakim T., Rider W. D., Cummings B. J., Ginsberg R. J., Cooper J. C. Radical radiation therapy with 5-fluorouracil infusion and mitomycin C for oesophageal squamous carcinoma. Radiother Oncol. 1985 Nov;4(3):205–210. doi: 10.1016/s0167-8140(85)80085-2. [DOI] [PubMed] [Google Scholar]
  7. Lokich J. J., Shea M., Chaffey J. Sequential infusional 5-fluorouracil followed by concomitant radiation for tumors of the esophagus and gastroesophageal junction. Cancer. 1987 Aug 1;60(3):275–279. doi: 10.1002/1097-0142(19870801)60:3<275::aid-cncr2820600302>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  8. MacKean J., Burmeister B. H., Lamb D. S., Denham J. W. Concurrent chemoradiation for oesophageal cancer: factors influencing myelotoxicity. Australas Radiol. 1996 Nov;40(4):424–429. doi: 10.1111/j.1440-1673.1996.tb00440.x. [DOI] [PubMed] [Google Scholar]
  9. Minsky B. D., Neuberg D., Kelsen D. P., Pisansky T. M., Ginsberg R., Benson A., 3rd Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122. J Clin Oncol. 1996 Jan;14(1):149–155. doi: 10.1200/JCO.1996.14.1.149. [DOI] [PubMed] [Google Scholar]
  10. Munro A. J. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer. 1995 Jan;71(1):83–91. doi: 10.1038/bjc.1995.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Parmar M. K., Spiegelhalter D. J., Freedman L. S. The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee. Stat Med. 1994 Jul 15;13(13-14):1297–1312. doi: 10.1002/sim.4780131304. [DOI] [PubMed] [Google Scholar]
  12. Poplin E. A., Khanuja P. S., Kraut M. J., Herskovic A. M., Lattin P. B., Cummings G., Gaspar L. E., Kinzie J. L., Steiger Z., Vaitkevicius V. K. Chemoradiotherapy of esophageal carcinoma. Cancer. 1994 Aug 15;74(4):1217–1224. doi: 10.1002/1097-0142(19940815)74:4<1217::aid-cncr2820740407>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  13. Powell M. E., Hoskin P. J., Saunders M. I., Foy C. J., Dische S. Continuous hyperfractionated accelerated radiotherapy (CHART) in localized cancer of the esophagus. Int J Radiat Oncol Biol Phys. 1997 Apr 1;38(1):133–136. doi: 10.1016/s0360-3016(96)00582-2. [DOI] [PubMed] [Google Scholar]
  14. Saunders M. I., Dische S., Barrett A., Parmar M. K., Harvey A., Gibson D. Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee. Br J Cancer. 1996 Jun;73(12):1455–1462. doi: 10.1038/bjc.1996.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Saunders M., Dische S., Barrett A., Harvey A., Gibson D., Parmar M. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee. Lancet. 1997 Jul 19;350(9072):161–165. doi: 10.1016/s0140-6736(97)06305-8. [DOI] [PubMed] [Google Scholar]
  16. Steel G. G. The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiother Oncol. 1988 Jan;11(1):31–53. doi: 10.1016/0167-8140(88)90044-8. [DOI] [PubMed] [Google Scholar]
  17. Tannock I. F. Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol. 1989 Oct;16(2):83–101. doi: 10.1016/0167-8140(89)90025-x. [DOI] [PubMed] [Google Scholar]
  18. Walsh T. N., Noonan N., Hollywood D., Kelly A., Keeling N., Hennessy T. P. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996 Aug 15;335(7):462–467. doi: 10.1056/NEJM199608153350702. [DOI] [PubMed] [Google Scholar]
  19. Yarnold J. R., Hoskin P. J., Powell S. N. Study design in the evaluation of combined radiotherapy plus chemotherapy. Eur J Cancer. 1990;26(7):773–775. doi: 10.1016/0277-5379(90)90147-l. [DOI] [PubMed] [Google Scholar]
  20. al-Sarraf M., Martz K., Herskovic A., Leichman L., Brindle J. S., Vaitkevicius V. K., Cooper J., Byhardt R., Davis L., Emami B. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol. 1997 Jan;15(1):277–284. doi: 10.1200/JCO.1997.15.1.277. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES